ePrior Authorization: Debunking the Myths

By Lash Group |

Designed to manage healthcare costs by creating a barrier to access for high-cost products, prior authorization (PA) has become a leading cause of frustration and treatment delays for providers and patients alike. 
Designed to manage healthcare costs by creating a barrier to access for high-cost products, prior authorization (PA) has become a leading cause of frustration and treatment delays for providers and patients alike. And while electronic solutions hold promise in terms of reducing administrative burden, reducing abandonment and improving outcomes via improved adherence and speed to therapy, some misconceptions exist that may be blocking healthcare stakeholders from experiencing the full benefit of ePA offerings. This infographic explores the ePA landscape and dispels three myths that challenge the integration of ePA into patient support programs.
Topics:
Market Access